839 related articles for article (PubMed ID: 20504915)
1. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M
J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915
[TBL] [Abstract][Full Text] [Related]
2. In vitro pharmacological characterization of a novel allosteric modulator of alpha 7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), exhibiting unique pharmacological profile.
Malysz J; Grønlien JH; Anderson DJ; Håkerud M; Thorin-Hagene K; Ween H; Wetterstrand C; Briggs CA; Faghih R; Bunnelle WH; Gopalakrishnan M
J Pharmacol Exp Ther; 2009 Jul; 330(1):257-67. PubMed ID: 19389923
[TBL] [Abstract][Full Text] [Related]
3. In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease.
Bitner RS; Bunnelle WH; Decker MW; Drescher KU; Kohlhaas KL; Markosyan S; Marsh KC; Nikkel AL; Browman K; Radek R; Anderson DJ; Buccafusco J; Gopalakrishnan M
J Pharmacol Exp Ther; 2010 Sep; 334(3):875-86. PubMed ID: 20504913
[TBL] [Abstract][Full Text] [Related]
4. JN403, in vitro characterization of a novel nicotinic acetylcholine receptor alpha7 selective agonist.
Feuerbach D; Nozulak J; Lingenhoehl K; McAllister K; Hoyer D
Neurosci Lett; 2007 Apr; 416(1):61-5. PubMed ID: 17314009
[TBL] [Abstract][Full Text] [Related]
5. Old and new pharmacology: positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine(2B/C) receptor antagonist SB-206553 (3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b']di pyrrole-1(2H)-carboxamide).
Dunlop J; Lock T; Jow B; Sitzia F; Grauer S; Jow F; Kramer A; Bowlby MR; Randall A; Kowal D; Gilbert A; Comery TA; Larocque J; Soloveva V; Brown J; Roncarati R
J Pharmacol Exp Ther; 2009 Mar; 328(3):766-76. PubMed ID: 19050173
[TBL] [Abstract][Full Text] [Related]
6. Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders.
Roncarati R; Scali C; Comery TA; Grauer SM; Aschmi S; Bothmann H; Jow B; Kowal D; Gianfriddo M; Kelley C; Zanelli U; Ghiron C; Haydar S; Dunlop J; Terstappen GC
J Pharmacol Exp Ther; 2009 May; 329(2):459-68. PubMed ID: 19223665
[TBL] [Abstract][Full Text] [Related]
7. Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes.
Grønlien JH; Håkerud M; Ween H; Thorin-Hagene K; Briggs CA; Gopalakrishnan M; Malysz J
Mol Pharmacol; 2007 Sep; 72(3):715-24. PubMed ID: 17565004
[TBL] [Abstract][Full Text] [Related]
8. Molecular dissection of tropisetron, an alpha7 nicotinic acetylcholine receptor-selective partial agonist.
Papke RL; Schiff HC; Jack BA; Horenstein NA
Neurosci Lett; 2005 Apr; 378(3):140-4. PubMed ID: 15781147
[TBL] [Abstract][Full Text] [Related]
9. An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo.
Timmermann DB; Grønlien JH; Kohlhaas KL; Nielsen EØ; Dam E; Jørgensen TD; Ahring PK; Peters D; Holst D; Christensen JK; Malysz J; Briggs CA; Gopalakrishnan M; Olsen GM
J Pharmacol Exp Ther; 2007 Oct; 323(1):294-307. PubMed ID: 17625074
[TBL] [Abstract][Full Text] [Related]
10. Effects of the novel α7 nicotinic acetylcholine receptor agonist ABT-107 on sensory gating in DBA/2 mice: pharmacodynamic characterization.
Radek RJ; Robb HM; Stevens KE; Gopalakrishnan M; Bitner RS
J Pharmacol Exp Ther; 2012 Dec; 343(3):736-45. PubMed ID: 22988063
[TBL] [Abstract][Full Text] [Related]
11. Alpha7 nAChR-mediated activation of MAP kinase pathways in PC12 cells.
Gubbins EJ; Gopalakrishnan M; Li J
Brain Res; 2010 Apr; 1328():1-11. PubMed ID: 20211606
[TBL] [Abstract][Full Text] [Related]
12. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS
J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
[TBL] [Abstract][Full Text] [Related]
13. Importance of M2-M3 loop in governing properties of genistein at the α7 nicotinic acetylcholine receptor inferred from α7/5-HT3A chimera.
Grønlien JH; Ween H; Thorin-Hagene K; Cassar S; Li J; Briggs CA; Gopalakrishnan M; Malysz J
Eur J Pharmacol; 2010 Nov; 647(1-3):37-47. PubMed ID: 20816816
[TBL] [Abstract][Full Text] [Related]
14. Local and global calcium signals associated with the opening of neuronal alpha7 nicotinic acetylcholine receptors.
Gilbert D; Lecchi M; Arnaudeau S; Bertrand D; Demaurex N
Cell Calcium; 2009 Feb; 45(2):198-207. PubMed ID: 19038445
[TBL] [Abstract][Full Text] [Related]
15. Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes.
Sydserff S; Sutton EJ; Song D; Quirk MC; Maciag C; Li C; Jonak G; Gurley D; Gordon JC; Christian EP; Doherty JJ; Hudzik T; Johnson E; Mrzljak L; Piser T; Smagin GN; Wang Y; Widzowski D; Smith JS
Biochem Pharmacol; 2009 Oct; 78(7):880-8. PubMed ID: 19615981
[TBL] [Abstract][Full Text] [Related]
16. Differential coupling of alpha7 and non-alpha7 nicotinic acetylcholine receptors to calcium-induced calcium release and voltage-operated calcium channels in PC12 cells.
Dickinson JA; Hanrott KE; Mok MH; Kew JN; Wonnacott S
J Neurochem; 2007 Feb; 100(4):1089-96. PubMed ID: 17181555
[TBL] [Abstract][Full Text] [Related]
17. Identification and in vitro pharmacological characterization of a novel and selective α7 nicotinic acetylcholine receptor agonist, Br-IQ17B.
Tang JS; Xie BX; Bian XL; Xue Y; Wei NN; Zhou JH; Hao YC; Li G; Zhang LR; Wang KW
Acta Pharmacol Sin; 2015 Jul; 36(7):800-12. PubMed ID: 25948478
[TBL] [Abstract][Full Text] [Related]
18. Presynaptic alpha 7- and beta 2-containing nicotinic acetylcholine receptors modulate excitatory amino acid release from rat prefrontal cortex nerve terminals via distinct cellular mechanisms.
Dickinson JA; Kew JN; Wonnacott S
Mol Pharmacol; 2008 Aug; 74(2):348-59. PubMed ID: 18445710
[TBL] [Abstract][Full Text] [Related]
19. A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization.
Hurst RS; Hajós M; Raggenbass M; Wall TM; Higdon NR; Lawson JA; Rutherford-Root KL; Berkenpas MB; Hoffmann WE; Piotrowski DW; Groppi VE; Allaman G; Ogier R; Bertrand S; Bertrand D; Arneric SP
J Neurosci; 2005 Apr; 25(17):4396-405. PubMed ID: 15858066
[TBL] [Abstract][Full Text] [Related]
20. [3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity alpha7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain.
Anderson DJ; Bunnelle W; Surber B; Du J; Surowy C; Tribollet E; Marguerat A; Bertrand D; Gopalakrishnan M
J Pharmacol Exp Ther; 2008 Jan; 324(1):179-87. PubMed ID: 17959745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
